apricusbio avatar

    apricusbio

    Apricus Biosciences
    San Diego

    Joined Mar 09, 2011

    http://www.apricusbio.com

    This website may contain links or references to other websites maintained by third parties and to comments made by third parties or other persons or entities over whom Apricus Bio has no control. Apricus Bio makes no warranties or representations of

    1. apricusbio
      $APRI Announces New Data Published in the International Journal of Pharmaceutics Confirming Efficiency of NexACT - http://stks.co/buK
      Oct. 13 at 12:31 PM
    2. apricusbio
      $APRI Announces Presentation of Efficacy and Clinical Safety Data for Vitaros® at Upcoming Industry Conference http://stks.co/Yoi
      Oct. 10 at 12:27 PM
    3. apricusbio
      Apricus Bio $APRI to Present Poster of Femprox® Phase III Clinical Data at Upcoming Industry Conference - http://stks.co/WL7
      Oct. 6 at 12:53 PM
    4. apricusbio
      Apricus Biosciences $APRI to Present NexACT® Technology Overview at PODD Drug Delivery Conference - http://stks.co/VON
      Oct. 5 at 4:57 PM
    5. apricusbio
      Apricus Biosciences $APRI Announces Korean Patent Approval for MycoVa™ for Nail Fungus - http://stks.co/Sca
      Oct. 3 at 12:43 PM
    6. apricusbio
      $APRI Announces Expansion of Its NexACT® Patent Portfolio http://stk.ly/qUVqPt
      Aug. 15 at 2:02 PM
    7. apricusbio
      $APRI Announces Second Quarter 2011 Financial Results Conference Call http://stk.ly/ngaBFB
      Aug. 11 at 5:31 PM
    8. apricusbio
      $APRI CEO Interviewed on CEOLIVE.TV http://stk.ly/razhpi
      Aug. 11 at 12:30 PM
    9. apricusbio
      Dr. Bassam Damaj, Chairman, President and Chief Executive Officer, of $APRI being interviewed by CEOLive: http://stk.ly/rfiu3Q
      Aug. 11 at 11:54 AM
    10. apricusbio
      $APRI to File for Market Authorization to Sell Vitaros® for Erectile Dysfunction in Latin America http://stk.ly/nzWQPa
      Aug. 8 at 12:41 PM
    11. apricusbio
      $APRI Provides Corporate Mid-Year Update http://stk.ly/pV4Cd7
      Aug. 8 at 11:05 AM
    12. apricusbio
      $APRI exhibiting at the 38th Annual Meeting & Exposition of the Controlled Release Society | July 30 - August 3, 2011 http://stk.ly/oLd4lF
      Jul. 28 at 11:29 AM
    13. apricusbio
      $APRI Files Marketing Application for Vitaros® as a Treatment for Erectile Dysfunction in Switzerland http://stk.ly/nmCCz2
      Jul. 19 at 12:52 PM
    14. apricusbio
      $APRI Sells Bio-Quant CRO Subsidiary to BioTox Sciences http://fb.me/wrCArBxk
      Jul. 6 at 3:53 PM
    15. apricusbio
      $APRI's Marketing Application for Vitaros®, for the Treatment of Erectile Dysfunction, is Accepted for Review in... http://fb.me/wDeSyxru
      Jun. 28 at 1:11 PM
      More

      Follow apricusbio on StockTwits!

      Follow investors and traders that match your style and get a personalized stream of news, charts, and ideas.

      Badges

      Earnings Announcement

      Listen to the earnings call

      APRI Information

      • Description:
        Apricus Biosciences ($APRI) is a NASDAQ-traded bio-pharmaceutical company dedicated to developing patient-friendly drugs focusing in the areas of dermatology, sexual dysfunction, cancer, auto-immune, pain, and metabolic diseases through its clinically-proven multi-route NexACT® drug delivery technolo ... more
      • IR Contact:
        Edward Cox
        VP of IR & Corporate Development
        ecox@apricusbio.com
      • Address:
        6330 Nancy Ridge Drive
        Suite 103
        San Diego, CA, 92121
        United States
      • Links:
      More